Dr Mark Cookson Professor Camille Carroll
| Twelve Years of Drug Prioritization to Help Accelerate Disease Modification Trials in Parkinson's Disease: The International Linked Clinical Trials Initiative | 2024 |
|
Dr Daniel Erskine Professor Alan Thomas Dr Ahmad Khundakar Dr Peter Hanson Professor John-Paul Taylor et al. | Molecular changes in the absence of severe pathology in the pulvinar in dementia with Lewy bodies | 2018 |
|
Mark Gibson Dr Jennifer Court Dr Mark Cookson
| alpha-synuclein implicated in Parkinson's disease is present in extracellular biological fluids, including human plasma | 2003 |
|
Dr Mark Cookson Fiona Menzies Dr Philip Manning Professor Christopher Eggett Emeritus Professor Calum McNeil et al. | Cu/Zn superoxide dismutase (SOD1) mutations associated with familial amyotrophic lateral sclerosis (ALS) affect cellular free radical release in the presence of oxidative stress | 2002 |
|
Emeritus Professor John Kirby Fiona Menzies Dr Mark Cookson Emerita Professor Katherine Bushby Professor Pamela Shaw et al. | Differential gene expression in a cell culture model of SOD1-related familial motor neurone disease | 2002 |
|
Fiona Menzies Dr Mark Cookson Professor Robert Taylor Emeritus Professor Doug Turnbull Professor Zofia Chrzanowska-Lightowlers et al. | Mitochondrial dysfunction in a cell culture model of familial amyotrophic lateral sclerosis | 2002 |
|
Dr Carmen Martin-Ruiz Dr Margaret Piggott Dr Mark Cookson Emeritus Professor Robert Perry Dr Evelyn Jaros et al. | Nicotinic receptors in the putamen of patients with dementia with Lewy bodies and Parkinson's disease: relation to changes in alpha-synuclein expression | 2002 |
|
Steven Banner Dr Anne Fray Dr Mark Cookson Professor Pamela Shaw
| The expression of the glutamate re-uptake transporter excitatory amino acid transporter 1 (EAAT1) in the normal human CNS and in motor neurone disease: An immunohistochemical study | 2002 |
|
Dr Rebecca Williams Dr Mark Cookson Dr Anne Fray Dr Philip Manning Fiona Menzies et al. | Cultured glial cells are resistant to the effects of motor neurone disease-associated SOD1 mutations | 2001 |
|
Dr Mark Cookson Professor Pamela Shaw
| Glial cells of the spinal cord and subcortical white matter up-regulate neuronal nitric oxide synthase in sporadic amyotrophic lateral sclerosis | 2001 |
|
Dr Anne Fray Susan Dempster Dr Rebecca Williams Dr Mark Cookson Professor Pamela Shaw et al. | Glutamine synthetase activity and expression are not affected by the development of motor neuronopathy in the G93A SOD-1/ALS mouse | 2001 |
|
Dr Philip Manning Dr Mark Cookson Emeritus Professor Calum McNeil Professor Pamela Shaw
| Superoxide-induced nitric oxide release from cultured glial cells | 2001 |
|
Dr Philip Manning Dr Mark Cookson Professor Christopher Eggett Professor Pamela Shaw Emeritus Professor Calum McNeil et al. | Real-time bioelectrochemical investigation of brain injury and neurodegeneration | 2000 |
|
Dr Philip Manning Dr Mark Cookson Professor Christopher Eggett Professor Anthony Thody Professor Pamela Shaw et al. | Real-time measurement of free radical production using specific electrochemical sensors: New insight into the consequences of O2/- and NO flux | 2000 |
|
Dr Janine Tomkins Susan Dempster Steven Banner Dr Mark Cookson Professor Pamela Shaw et al. | Screening of AP endonuclease as a candidate gene for amyotrophic lateral sclerosis (ALS) | 2000 |
|
Dr Mark Cookson Professor Pamela Shaw
| Oxidative stress and motor neurone disease | 1999 |
|
Dr Mark Cookson Professor Pamela Shaw
| Poly(ADP-ribose) polymerase is found in both the nucleus and cytoplasm of human CNS neurons | 1999 |
|